Tanya Tekautz
Overview
Explore the profile of Tanya Tekautz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahar M, Hashem H, Tekautz T, Worley S, Tang A, de Blank P, et al.
J Neurooncol
. 2017 Mar;
132(3):427-432.
PMID: 28290001
Choroid plexus tumors (CPT) are rare neoplasms accounting for 1-4% of all pediatric brain tumors. They are divided into choroid plexus papilloma (CPP), atypical choroid plexus papilloma (APP) and choroid...
2.
Dhir A, Tekautz T, Recinos V, Murphy E, Prayson R, Ruggieri P, et al.
J Clin Neurosci
. 2015 Aug;
22(12):1988-9.
PMID: 26234633
We describe a pediatric patient with an atypical teratoid rhabdoid tumor (AT/RT) exclusively of the lumbar spine, with a different presentation from the two previously reported pediatric lumbar AT/RT. AT/RT...
3.
Bahar M, Kordes U, Tekautz T, Wolff J
Anticancer Res
. 2015 May;
35(5):3013-7.
PMID: 25964589
Background: Choroid plexus carcinomas (CPCs) are rare pediatric tumors often associated with Li-Fraumeni Syndrome (LFS), a germline mutation in the TP53 tumor-suppressor gene, predisposing to cancer. Materials And Methods: We...
4.
Venkatramani R, Ji L, Lasky J, Haley K, Judkins A, Zhou S, et al.
J Neurooncol
. 2013 Mar;
113(2):285-91.
PMID: 23508296
This study investigates the outcome of children <10 years old with newly-diagnosed ependymoma treated on the prospective multinational "Head Start" III clinical trial. Between April 2004 and July 2009, 19...
5.
Ghosh P, Tekautz T, Mitra S
Neurology
. 2012 Jan;
78(2):e8-10.
PMID: 22232058
No abstract available.
6.
Ahluwalia M, Patton C, Stevens G, Tekautz T, Angelov L, Vogelbaum M, et al.
J Neurooncol
. 2010 Aug;
102(2):317-21.
PMID: 20683757
Current therapies for recurrent or progressive high-grade gliomas (HGG, WHO grade 3-4) produce a 6-month progression-free survival of only 10-25%. Migration and invasion by HGG is mediated in part by...
7.
Garre M, Tekautz T
Pediatr Blood Cancer
. 2010 Feb;
54(4):647-8.
PMID: 20146222
Atypical teratoid/rhabdoid tumors (AT/RTs) of the CNS have been recently characterized as a distinct clinicopathologic entity with an unusually poor prognosis and with the highest incidence in the first 2...
8.
Phillips N, Sanford R, Helton K, Boop F, Zou P, Tekautz T, et al.
J Neurosurg
. 2005 Dec;
103(6 Suppl):557-62.
PMID: 16383256
Brainstem gliomas are a heterogeneous group of lesions that account for 15% of all pediatric tumors of the central nervous system. Diagnosis and treatment planning for these tumors is based...
9.
Barfield R, Hill D, Hoffer F, Tekautz T, Spunt S
Med Pediatr Oncol
. 2002 Jul;
39(2):120-4.
PMID: 12116060
No abstract available.